Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types

Fig. 2

Effects of SLC31A1 expression on overall survival in different TCGA tumor types. a An overview survival map and overall survival analyses b–i are derived from GEPIA2. Kaplan–Meier plots of cancer types with significant p-values are shown. The 95% confidence intervals of overall survival are indicated by red and blue dotted lines for high and low SLC31A1 expression groups, respectively. The color of the squares indicates the value of hazzard ratio (HR). Squares with bold outlines in the survival map denote p(HR) < 0.05

Back to article page